John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 93,601 shares at $6.61 ($585K) on 2022-06-07, disclosed to the SEC on 2022-06-07.
Open-market sale of $585k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.05 | 15,230 | $92K | 15.7% |
| 2 | $6.05 | 15,230 | $92K | 15.7% |
| 3 | $6.03 | 13,934 | $84K | 14.4% |
| 4 | $6.03 | 13,934 | $84K | 14.4% |
| 5 | $6.61 | 973 | $6K | 1.1% |
| 6 | $6.61 | 17,150 |
| $113K |
| 19.4% |
| 7 | $6.61 | 17,150 | $113K | 19.4% |
| Total | $6.26 avg | 93,601 | $585K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |